Home › Funds › GLENVIEW CAPITAL MANAGEMENT, LLC › EYE

GLENVIEW CAPITAL MANAGEMENT, LLC position in EYE

NATIONAL VISION HLDGS INC · Health Care

GLENVIEW CAPITAL MANAGEMENT, LLC reported holding 3,101,083 shares of EYE (NATIONAL VISION HLDGS INC) in its Q2 2026 13F filing — a position valued at US$59.0M, representing 1.13% of its reported portfolio and ranking #24 among its reported holdings. GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed EYE holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)3.10M sh
Reported value held$58.95M
Portfolio Weight1.13%
First reportedQ2 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GLENVIEW CAPITAL MANAGEMENT, LLC's EYE position evolved

GLENVIEW CAPITAL MANAGEMENT, LLC first disclosed a stake in EYE in Q2 2025 at 812,534 shares (US$18.7M). The position peaked in Q2 2026 at 3,101,083 shares, worth US$59.0M. Across 5 filings, GLENVIEW CAPITAL MANAGEMENT, LLC increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 3,101,083 shares valued at US$59.0M — an increase of 1,535,166 shares quarter over quarter.. Notable position changes include a 70% increase in Q3 2025 (shares fell 12% over the following quarter), a 98% increase in Q2 2026 (shares fell 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 812.53K $18.70M New
Q3 2025 1.38M $40.23M Add
Q4 2025 1.43M $36.91M Add
Q1 2026 1.57M $40.56M Add
Q2 2026 3.10M $58.95M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EYE and 13F data

EYE (NATIONAL VISION HLDGS INC) is a Health Care company. 30 other funds we track also report a position in EYE — the largest reported positions include Engine Capital Management, LP (US$66.9M), EMERALD ADVISERS, LLC (US$38.1M), Divisadero Street Capital Management, LP (US$36.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EYE

All EYE fund holders →

FAQ

How long has GLENVIEW CAPITAL MANAGEMENT, LLC held EYE?

GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed EYE holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is GLENVIEW CAPITAL MANAGEMENT, LLC's current position in EYE?

As of Q2 2026, GLENVIEW CAPITAL MANAGEMENT, LLC holds 3.10M shares of EYE (NATIONAL VISION HLDGS INC), valued at $58.95M, representing 1.13% of its reported portfolio and ranking #24.

Has GLENVIEW CAPITAL MANAGEMENT, LLC been buying or selling EYE?

In the latest 13F filing (Q2 2026), GLENVIEW CAPITAL MANAGEMENT, LLC increased its position in EYE. The position peaked in Q2 2026 at 3.10M shares.

Which other funds hold EYE?

Other major institutional holders of EYE include Engine Capital Management, LP, EMERALD ADVISERS, LLC, Divisadero Street Capital Management, LP, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.